Myung Ah Lee

Durvalumab plus gemcitabine and cisplatin in advanced biliary tract cancer (TOPAZ-1): patient-reported outcomes from a randomised, double-blind, placebo-controlled, phase 3 trial.

N. Rokutanda, T. Okusaka, V. Breder, 2024, The Lancet. Oncology.

Comparison of thymidine phosphorylase expression and prognostic factors in gallbladder and bile duct cancer

T. Hong, Myung Ah Lee, Hye Sung Won, 2010, BMC Cancer.